Načítá se...
Effect of edaravone therapy in Korean amyotrophic lateral sclerosis (ALS) patients
Oxidative stress caused by free radicals has been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS). Edaravone (also known as MCI-186), a free radical scavenger, was approved as an ALS treatment in 2015 in Japan. However, the therapeutic effects of edaravone on patients with ALS...
Uloženo v:
| Vydáno v: | Neurol Sci |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer International Publishing
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7223963/ https://ncbi.nlm.nih.gov/pubmed/31471712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10072-019-04055-3 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|